nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxylamine—Body temperature decreased—Metformin—polycystic ovary syndrome	0.0352	0.0811	CcSEcCtD
Doxylamine—Hypothermia—Metformin—polycystic ovary syndrome	0.0352	0.0811	CcSEcCtD
Doxylamine—Rhinorrhoea—Metformin—polycystic ovary syndrome	0.0243	0.0561	CcSEcCtD
Doxylamine—Dehydration—Metformin—polycystic ovary syndrome	0.0133	0.0307	CcSEcCtD
Doxylamine—Breast disorder—Metformin—polycystic ovary syndrome	0.0129	0.0298	CcSEcCtD
Doxylamine—Cramp muscle—Metformin—polycystic ovary syndrome	0.0129	0.0297	CcSEcCtD
Doxylamine—Nasopharyngitis—Metformin—polycystic ovary syndrome	0.0128	0.0295	CcSEcCtD
Doxylamine—Pancreatitis—Metformin—polycystic ovary syndrome	0.0121	0.028	CcSEcCtD
Doxylamine—Sweating increased—Metformin—polycystic ovary syndrome	0.0121	0.0278	CcSEcCtD
Doxylamine—Abdominal discomfort—Metformin—polycystic ovary syndrome	0.0119	0.0273	CcSEcCtD
Doxylamine—Drowsiness—Metformin—polycystic ovary syndrome	0.011	0.0254	CcSEcCtD
Doxylamine—Bradycardia—Metformin—polycystic ovary syndrome	0.0101	0.0232	CcSEcCtD
Doxylamine—Hepatitis—Metformin—polycystic ovary syndrome	0.00991	0.0228	CcSEcCtD
Doxylamine—Eye disorder—Metformin—polycystic ovary syndrome	0.00926	0.0213	CcSEcCtD
Doxylamine—Cardiac disorder—Metformin—polycystic ovary syndrome	0.00919	0.0212	CcSEcCtD
Doxylamine—Flushing—Metformin—polycystic ovary syndrome	0.00919	0.0212	CcSEcCtD
Doxylamine—Immune system disorder—Metformin—polycystic ovary syndrome	0.00895	0.0206	CcSEcCtD
Doxylamine—Mediastinal disorder—Metformin—polycystic ovary syndrome	0.00893	0.0206	CcSEcCtD
Doxylamine—Erythema—Metformin—polycystic ovary syndrome	0.00862	0.0199	CcSEcCtD
Doxylamine—Muscle spasms—Metformin—polycystic ovary syndrome	0.00829	0.0191	CcSEcCtD
Doxylamine—Tremor—Metformin—polycystic ovary syndrome	0.00808	0.0186	CcSEcCtD
Doxylamine—Ill-defined disorder—Metformin—polycystic ovary syndrome	0.008	0.0184	CcSEcCtD
Doxylamine—Malaise—Metformin—polycystic ovary syndrome	0.00778	0.0179	CcSEcCtD
Doxylamine—Palpitations—Metformin—polycystic ovary syndrome	0.00762	0.0176	CcSEcCtD
Doxylamine—Discomfort—Metformin—polycystic ovary syndrome	0.00725	0.0167	CcSEcCtD
Doxylamine—Nervous system disorder—Metformin—polycystic ovary syndrome	0.0069	0.0159	CcSEcCtD
Doxylamine—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.00689	0.0159	CcSEcCtD
Doxylamine—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.0068	0.0157	CcSEcCtD
Doxylamine—Anorexia—Metformin—polycystic ovary syndrome	0.00671	0.0155	CcSEcCtD
Doxylamine—Hypotension—Metformin—polycystic ovary syndrome	0.00658	0.0152	CcSEcCtD
Doxylamine—Dyspnoea—Metformin—polycystic ovary syndrome	0.00627	0.0145	CcSEcCtD
Doxylamine—Somnolence—Metformin—polycystic ovary syndrome	0.00626	0.0144	CcSEcCtD
Doxylamine—Decreased appetite—Metformin—polycystic ovary syndrome	0.00612	0.0141	CcSEcCtD
Doxylamine—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.00608	0.014	CcSEcCtD
Doxylamine—Fatigue—Metformin—polycystic ovary syndrome	0.00607	0.014	CcSEcCtD
Doxylamine—Constipation—Metformin—polycystic ovary syndrome	0.00602	0.0139	CcSEcCtD
Doxylamine—Feeling abnormal—Metformin—polycystic ovary syndrome	0.0058	0.0134	CcSEcCtD
Doxylamine—Urticaria—Metformin—polycystic ovary syndrome	0.00559	0.0129	CcSEcCtD
Doxylamine—Asthenia—Metformin—polycystic ovary syndrome	0.00505	0.0116	CcSEcCtD
Doxylamine—Pruritus—Metformin—polycystic ovary syndrome	0.00498	0.0115	CcSEcCtD
Doxylamine—Diarrhoea—Metformin—polycystic ovary syndrome	0.00482	0.0111	CcSEcCtD
Doxylamine—Dizziness—Metformin—polycystic ovary syndrome	0.00465	0.0107	CcSEcCtD
Doxylamine—Vomiting—Metformin—polycystic ovary syndrome	0.00447	0.0103	CcSEcCtD
Doxylamine—Rash—Metformin—polycystic ovary syndrome	0.00444	0.0102	CcSEcCtD
Doxylamine—Dermatitis—Metformin—polycystic ovary syndrome	0.00443	0.0102	CcSEcCtD
Doxylamine—Doxepin—ADRA1D—polycystic ovary syndrome	0.00441	0.0863	CrCbGaD
Doxylamine—Nausea—Metformin—polycystic ovary syndrome	0.00418	0.00963	CcSEcCtD
Doxylamine—Promazine—ADRA1D—polycystic ovary syndrome	0.00392	0.0767	CrCbGaD
Doxylamine—Doxepin—ADRA1B—polycystic ovary syndrome	0.00376	0.0736	CrCbGaD
Doxylamine—Imipramine—ADRA1D—polycystic ovary syndrome	0.00343	0.0671	CrCbGaD
Doxylamine—Amitriptyline—ADRA1D—polycystic ovary syndrome	0.00341	0.0667	CrCbGaD
Doxylamine—Promazine—ADRA1B—polycystic ovary syndrome	0.00334	0.0654	CrCbGaD
Doxylamine—Benzphetamine—ADRA1A—polycystic ovary syndrome	0.00325	0.0637	CrCbGaD
Doxylamine—Toremifene—CYP1A1—polycystic ovary syndrome	0.00324	0.0635	CrCbGaD
Doxylamine—Levomethadyl Acetate—CYP19A1—polycystic ovary syndrome	0.00298	0.0583	CrCbGaD
Doxylamine—Imipramine—ADRA1B—polycystic ovary syndrome	0.00293	0.0573	CrCbGaD
Doxylamine—Amitriptyline—ADRA1B—polycystic ovary syndrome	0.00291	0.0569	CrCbGaD
Doxylamine—Doxepin—ADRA1A—polycystic ovary syndrome	0.00253	0.0496	CrCbGaD
Doxylamine—Promazine—ADRA1A—polycystic ovary syndrome	0.00225	0.044	CrCbGaD
Doxylamine—Imipramine—ADRA1A—polycystic ovary syndrome	0.00197	0.0386	CrCbGaD
Doxylamine—Amitriptyline—ADRA1A—polycystic ovary syndrome	0.00196	0.0383	CrCbGaD
Doxylamine—Tamoxifen—CYP19A1—polycystic ovary syndrome	0.00176	0.0345	CrCbGaD
Doxylamine—Methadone—CYP19A1—polycystic ovary syndrome	0.00174	0.0342	CrCbGaD
Doxylamine—CHRM1—Class A/1 (Rhodopsin-like receptors)—FSHR—polycystic ovary syndrome	0.00172	0.00334	CbGpPWpGaD
Doxylamine—HRH1—GPCR ligand binding—PTAFR—polycystic ovary syndrome	0.00168	0.00326	CbGpPWpGaD
Doxylamine—CHRM1—GPCR ligand binding—PTAFR—polycystic ovary syndrome	0.00168	0.00325	CbGpPWpGaD
Doxylamine—CHRM1—Circadian rythm related genes—NAMPT—polycystic ovary syndrome	0.00167	0.00324	CbGpPWpGaD
Doxylamine—HRH1—GPCR ligand binding—ADRA1D—polycystic ovary syndrome	0.00163	0.00317	CbGpPWpGaD
Doxylamine—CHRM1—GPCR ligand binding—ADRA1D—polycystic ovary syndrome	0.00163	0.00316	CbGpPWpGaD
Doxylamine—HRH1—GPCR ligand binding—ADRA1B—polycystic ovary syndrome	0.00159	0.00308	CbGpPWpGaD
Doxylamine—CHRM1—GPCR ligand binding—ADRA1B—polycystic ovary syndrome	0.00158	0.00307	CbGpPWpGaD
Doxylamine—HRH1—Class A/1 (Rhodopsin-like receptors)—ADRA1A—polycystic ovary syndrome	0.00158	0.00307	CbGpPWpGaD
Doxylamine—CHRM1—Class A/1 (Rhodopsin-like receptors)—ADRA1A—polycystic ovary syndrome	0.00157	0.00306	CbGpPWpGaD
Doxylamine—HRH1—GPCRs, Class A Rhodopsin-like—MTNR1B—polycystic ovary syndrome	0.00157	0.00304	CbGpPWpGaD
Doxylamine—CHRM1—GPCRs, Class A Rhodopsin-like—MTNR1B—polycystic ovary syndrome	0.00156	0.00303	CbGpPWpGaD
Doxylamine—HRH1—Class A/1 (Rhodopsin-like receptors)—ADRB3—polycystic ovary syndrome	0.00152	0.00295	CbGpPWpGaD
Doxylamine—CHRM1—Circadian rythm related genes—TOP2A—polycystic ovary syndrome	0.00152	0.00294	CbGpPWpGaD
Doxylamine—CHRM1—Class A/1 (Rhodopsin-like receptors)—ADRB3—polycystic ovary syndrome	0.00152	0.00294	CbGpPWpGaD
Doxylamine—HRH1—Class A/1 (Rhodopsin-like receptors)—LHB—polycystic ovary syndrome	0.0015	0.00292	CbGpPWpGaD
Doxylamine—HRH1—G alpha (q) signalling events—GHRL—polycystic ovary syndrome	0.0015	0.00291	CbGpPWpGaD
Doxylamine—CHRM1—Class A/1 (Rhodopsin-like receptors)—LHB—polycystic ovary syndrome	0.0015	0.00291	CbGpPWpGaD
Doxylamine—CHRM1—G alpha (q) signalling events—GHRL—polycystic ovary syndrome	0.00149	0.0029	CbGpPWpGaD
Doxylamine—CHRM1—Calcium Regulation in the Cardiac Cell—ADRB2—polycystic ovary syndrome	0.00148	0.00288	CbGpPWpGaD
Doxylamine—HRH1—Class A/1 (Rhodopsin-like receptors)—GNRH1—polycystic ovary syndrome	0.00147	0.00285	CbGpPWpGaD
Doxylamine—CHRM1—Class A/1 (Rhodopsin-like receptors)—GNRH1—polycystic ovary syndrome	0.00146	0.00284	CbGpPWpGaD
Doxylamine—CHRM1—Circadian rythm related genes—GHRL—polycystic ovary syndrome	0.00141	0.00274	CbGpPWpGaD
Doxylamine—CHRM1—Calcium Regulation in the Cardiac Cell—GNAS—polycystic ovary syndrome	0.00137	0.00267	CbGpPWpGaD
Doxylamine—CHRM1—Circadian rythm related genes—ADIPOQ—polycystic ovary syndrome	0.00136	0.00265	CbGpPWpGaD
Doxylamine—HRH1—Class A/1 (Rhodopsin-like receptors)—MTNR1B—polycystic ovary syndrome	0.00134	0.00261	CbGpPWpGaD
Doxylamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—GHRL—polycystic ovary syndrome	0.00134	0.0026	CbGpPWpGaD
Doxylamine—CHRM1—Class A/1 (Rhodopsin-like receptors)—MTNR1B—polycystic ovary syndrome	0.00134	0.0026	CbGpPWpGaD
Doxylamine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—GHRL—polycystic ovary syndrome	0.00134	0.00259	CbGpPWpGaD
Doxylamine—CHRM1—Circadian rythm related genes—TH—polycystic ovary syndrome	0.00132	0.00257	CbGpPWpGaD
Doxylamine—HRH1—GPCR ligand binding—FSHR—polycystic ovary syndrome	0.00132	0.00255	CbGpPWpGaD
Doxylamine—CHRM1—GPCR ligand binding—FSHR—polycystic ovary syndrome	0.00131	0.00255	CbGpPWpGaD
Doxylamine—Tamoxifen—CYP1A1—polycystic ovary syndrome	0.00129	0.0254	CrCbGaD
Doxylamine—CHRM1—Circadian rythm related genes—NGFR—polycystic ovary syndrome	0.00124	0.00241	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—NPB—polycystic ovary syndrome	0.00122	0.00236	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—NPB—polycystic ovary syndrome	0.00121	0.00236	CbGpPWpGaD
Doxylamine—HRH1—GPCR ligand binding—ADRA1A—polycystic ovary syndrome	0.0012	0.00234	CbGpPWpGaD
Doxylamine—CHRM1—GPCR ligand binding—ADRA1A—polycystic ovary syndrome	0.0012	0.00233	CbGpPWpGaD
Doxylamine—HRH1—GPCR ligand binding—ADRB3—polycystic ovary syndrome	0.00116	0.00225	CbGpPWpGaD
Doxylamine—CHRM1—GPCR ligand binding—ADRB3—polycystic ovary syndrome	0.00115	0.00224	CbGpPWpGaD
Doxylamine—HRH1—GPCR ligand binding—LHB—polycystic ovary syndrome	0.00114	0.00222	CbGpPWpGaD
Doxylamine—CHRM1—GPCR ligand binding—LHB—polycystic ovary syndrome	0.00114	0.00221	CbGpPWpGaD
Doxylamine—HRH1—GPCR ligand binding—GNRH1—polycystic ovary syndrome	0.00112	0.00217	CbGpPWpGaD
Doxylamine—CHRM1—GPCR ligand binding—GNRH1—polycystic ovary syndrome	0.00111	0.00216	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—NPB—polycystic ovary syndrome	0.0011	0.00215	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—NPB—polycystic ovary syndrome	0.0011	0.00214	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—PLEKHG5—polycystic ovary syndrome	0.0011	0.00214	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—PLEKHG5—polycystic ovary syndrome	0.0011	0.00213	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—ARHGAP30—polycystic ovary syndrome	0.00108	0.00209	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—ARHGAP23—polycystic ovary syndrome	0.00108	0.00209	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—ARHGAP30—polycystic ovary syndrome	0.00107	0.00209	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—ARHGAP23—polycystic ovary syndrome	0.00107	0.00209	CbGpPWpGaD
Doxylamine—HRH1—GPCR ligand binding—SCT—polycystic ovary syndrome	0.00107	0.00208	CbGpPWpGaD
Doxylamine—CHRM1—GPCR ligand binding—SCT—polycystic ovary syndrome	0.00107	0.00208	CbGpPWpGaD
Doxylamine—CHRM1—Circadian rythm related genes—NCOR1—polycystic ovary syndrome	0.00103	0.002	CbGpPWpGaD
Doxylamine—HRH1—GPCR ligand binding—MTNR1B—polycystic ovary syndrome	0.00102	0.00199	CbGpPWpGaD
Doxylamine—CHRM1—GPCR ligand binding—MTNR1B—polycystic ovary syndrome	0.00102	0.00198	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—PTGER3—polycystic ovary syndrome	0.00102	0.00197	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—LHCGR—polycystic ovary syndrome	0.00102	0.00197	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—PTGER3—polycystic ovary syndrome	0.00101	0.00197	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—LHCGR—polycystic ovary syndrome	0.00101	0.00197	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—PLEKHG5—polycystic ovary syndrome	0.000999	0.00194	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—PLEKHG5—polycystic ovary syndrome	0.000996	0.00193	CbGpPWpGaD
Doxylamine—HRH1—Class A/1 (Rhodopsin-like receptors)—GHRL—polycystic ovary syndrome	0.000992	0.00193	CbGpPWpGaD
Doxylamine—CHRM1—Class A/1 (Rhodopsin-like receptors)—GHRL—polycystic ovary syndrome	0.000989	0.00192	CbGpPWpGaD
Doxylamine—HRH1—GPCRs, Class A Rhodopsin-like—ADRB2—polycystic ovary syndrome	0.000958	0.00186	CbGpPWpGaD
Doxylamine—CHRM1—GPCRs, Class A Rhodopsin-like—ADRB2—polycystic ovary syndrome	0.000955	0.00186	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—PTAFR—polycystic ovary syndrome	0.00095	0.00184	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—PTAFR—polycystic ovary syndrome	0.000947	0.00184	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—LHCGR—polycystic ovary syndrome	0.000922	0.00179	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—PTGER3—polycystic ovary syndrome	0.000922	0.00179	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—ADRA1D—polycystic ovary syndrome	0.000922	0.00179	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—LHCGR—polycystic ovary syndrome	0.000919	0.00178	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—PTGER3—polycystic ovary syndrome	0.000919	0.00178	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—ADRA1D—polycystic ovary syndrome	0.000919	0.00178	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—ADRA1B—polycystic ovary syndrome	0.000897	0.00174	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—ADRA1B—polycystic ovary syndrome	0.000894	0.00174	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—PTAFR—polycystic ovary syndrome	0.000862	0.00167	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—PTAFR—polycystic ovary syndrome	0.00086	0.00167	CbGpPWpGaD
Doxylamine—CHRM1—Circadian rythm related genes—LEP—polycystic ovary syndrome	0.000848	0.00165	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—ADRA1D—polycystic ovary syndrome	0.000837	0.00163	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—ADRA1D—polycystic ovary syndrome	0.000835	0.00162	CbGpPWpGaD
Doxylamine—HRH1—Class A/1 (Rhodopsin-like receptors)—ADRB2—polycystic ovary syndrome	0.000821	0.00159	CbGpPWpGaD
Doxylamine—CHRM1—Class A/1 (Rhodopsin-like receptors)—ADRB2—polycystic ovary syndrome	0.000818	0.00159	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—PDE3B—polycystic ovary syndrome	0.000816	0.00158	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—ADRA1B—polycystic ovary syndrome	0.000814	0.00158	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—PDE3B—polycystic ovary syndrome	0.000813	0.00158	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—ADRA1B—polycystic ovary syndrome	0.000812	0.00158	CbGpPWpGaD
Doxylamine—HRH1—GPCR ligand binding—GHRL—polycystic ovary syndrome	0.000755	0.00147	CbGpPWpGaD
Doxylamine—CHRM1—GPCR ligand binding—GHRL—polycystic ovary syndrome	0.000753	0.00146	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—FLT4—polycystic ovary syndrome	0.000747	0.00145	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—FLT4—polycystic ovary syndrome	0.000744	0.00145	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—FSHR—polycystic ovary syndrome	0.000743	0.00144	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—PDE3B—polycystic ovary syndrome	0.000741	0.00144	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—FSHR—polycystic ovary syndrome	0.000741	0.00144	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—PDE3B—polycystic ovary syndrome	0.000739	0.00143	CbGpPWpGaD
Doxylamine—CHRM1—Circadian rythm related genes—PPARG—polycystic ovary syndrome	0.000738	0.00143	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—ADRA1A—polycystic ovary syndrome	0.00068	0.00132	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—ADRA1A—polycystic ovary syndrome	0.000678	0.00132	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—FSHR—polycystic ovary syndrome	0.000675	0.00131	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—FSHR—polycystic ovary syndrome	0.000673	0.00131	CbGpPWpGaD
Doxylamine—CHRM1—Circadian rythm related genes—SERPINE1—polycystic ovary syndrome	0.000665	0.00129	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—ADRB3—polycystic ovary syndrome	0.000654	0.00127	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—NPB—polycystic ovary syndrome	0.000653	0.00127	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—ADRB3—polycystic ovary syndrome	0.000652	0.00127	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—NPB—polycystic ovary syndrome	0.000651	0.00126	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—LHB—polycystic ovary syndrome	0.000647	0.00126	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—LHB—polycystic ovary syndrome	0.000644	0.00125	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	0.000632	0.00123	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	0.00063	0.00122	CbGpPWpGaD
Doxylamine—HRH1—GPCR ligand binding—ADRB2—polycystic ovary syndrome	0.000625	0.00121	CbGpPWpGaD
Doxylamine—CHRM1—GPCR ligand binding—ADRB2—polycystic ovary syndrome	0.000623	0.00121	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—ADRA1A—polycystic ovary syndrome	0.000617	0.0012	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—ADRA1A—polycystic ovary syndrome	0.000615	0.00119	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—SCT—polycystic ovary syndrome	0.000606	0.00118	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—SCT—polycystic ovary syndrome	0.000604	0.00117	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—ADRB3—polycystic ovary syndrome	0.000594	0.00115	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—ADRB3—polycystic ovary syndrome	0.000592	0.00115	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	0.00059	0.00115	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	0.000588	0.00114	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—LHB—polycystic ovary syndrome	0.000587	0.00114	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—LHB—polycystic ovary syndrome	0.000585	0.00114	CbGpPWpGaD
Doxylamine—HRH1—GPCR ligand binding—GNAS—polycystic ovary syndrome	0.00058	0.00113	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	0.000578	0.00112	CbGpPWpGaD
Doxylamine—CHRM1—GPCR ligand binding—GNAS—polycystic ovary syndrome	0.000578	0.00112	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	0.000576	0.00112	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—GNRH1—polycystic ovary syndrome	0.000574	0.00111	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—GNRH1—polycystic ovary syndrome	0.000572	0.00111	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—SCT—polycystic ovary syndrome	0.00055	0.00107	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—SCT—polycystic ovary syndrome	0.000548	0.00107	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—PTGER3—polycystic ovary syndrome	0.000545	0.00106	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—LHCGR—polycystic ovary syndrome	0.000545	0.00106	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—PTGER3—polycystic ovary syndrome	0.000543	0.00105	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—LHCGR—polycystic ovary syndrome	0.000543	0.00105	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	0.000525	0.00102	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	0.000523	0.00102	CbGpPWpGaD
Doxylamine—HRH1—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	0.000513	0.000995	CbGpPWpGaD
Doxylamine—CHRM1—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	0.000511	0.000992	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—PTAFR—polycystic ovary syndrome	0.000509	0.000989	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—PTAFR—polycystic ovary syndrome	0.000508	0.000986	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—ADRA1D—polycystic ovary syndrome	0.000495	0.000961	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—ADRA1D—polycystic ovary syndrome	0.000493	0.000957	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—ADRA1B—polycystic ovary syndrome	0.000481	0.000934	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—ADRA1B—polycystic ovary syndrome	0.00048	0.000931	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—INHBB—polycystic ovary syndrome	0.000469	0.000911	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—INHBB—polycystic ovary syndrome	0.000467	0.000908	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.000438	0.00085	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.000436	0.000847	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—GHRL—polycystic ovary syndrome	0.000427	0.000829	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—GHRL—polycystic ovary syndrome	0.000425	0.000826	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—FSHR—polycystic ovary syndrome	0.000399	0.000774	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—FSHR—polycystic ovary syndrome	0.000397	0.000772	CbGpPWpGaD
Doxylamine—HRH1—GPCR ligand binding—POMC—polycystic ovary syndrome	0.00039	0.000758	CbGpPWpGaD
Doxylamine—CHRM1—GPCR ligand binding—POMC—polycystic ovary syndrome	0.000389	0.000756	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.000388	0.000753	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.000386	0.00075	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000375	0.000728	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000374	0.000726	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000365	0.000708	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000363	0.000706	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—FST—polycystic ovary syndrome	0.000355	0.00069	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—FST—polycystic ovary syndrome	0.000354	0.000688	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000353	0.000686	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000352	0.000684	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000351	0.000682	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.00035	0.000679	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—LHB—polycystic ovary syndrome	0.000347	0.000674	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—LHB—polycystic ovary syndrome	0.000346	0.000671	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000339	0.000658	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000338	0.000656	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000328	0.000638	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000328	0.000636	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000327	0.000636	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000327	0.000634	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—SCT—polycystic ovary syndrome	0.000325	0.000631	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—SCT—polycystic ovary syndrome	0.000324	0.000629	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000321	0.000623	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.00032	0.000621	CbGpPWpGaD
Doxylamine—CHRM1—Circadian rythm related genes—IL6—polycystic ovary syndrome	0.000316	0.000615	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.00031	0.000602	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000309	0.0006	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000305	0.000592	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000304	0.00059	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000302	0.000587	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000301	0.000585	CbGpPWpGaD
Doxylamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	0.000301	0.000584	CbGpPWpGaD
Doxylamine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	0.0003	0.000582	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000298	0.000578	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000297	0.000576	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000282	0.000548	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000281	0.000546	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000278	0.00054	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000277	0.000539	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—INSR—polycystic ovary syndrome	0.000266	0.000517	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—INSR—polycystic ovary syndrome	0.000265	0.000515	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000253	0.000491	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000252	0.000489	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000249	0.000483	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000248	0.000482	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—PGR—polycystic ovary syndrome	0.000246	0.000478	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—PGR—polycystic ovary syndrome	0.000246	0.000477	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000229	0.000445	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000229	0.000445	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000228	0.000443	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000228	0.000443	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000221	0.000428	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.00022	0.000427	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000218	0.000424	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000218	0.000423	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000213	0.000414	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000212	0.000412	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000212	0.000412	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000211	0.00041	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000202	0.000392	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000201	0.00039	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—POMC—polycystic ovary syndrome	0.0002	0.000389	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—PRL—polycystic ovary syndrome	0.0002	0.000388	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—POMC—polycystic ovary syndrome	0.0002	0.000388	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—PRL—polycystic ovary syndrome	0.000199	0.000387	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000193	0.000374	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000192	0.000373	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.00019	0.000368	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000189	0.000367	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000176	0.000341	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000175	0.00034	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000167	0.000325	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000167	0.000324	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000164	0.000319	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000164	0.000318	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000141	0.000273	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—IRS2—polycystic ovary syndrome	0.00014	0.000272	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—LEP—polycystic ovary syndrome	0.000138	0.000268	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—LEP—polycystic ovary syndrome	0.000137	0.000267	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—IRS1—polycystic ovary syndrome	0.000123	0.000239	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—IRS1—polycystic ovary syndrome	0.000122	0.000238	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—POMC—polycystic ovary syndrome	0.000118	0.00023	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—POMC—polycystic ovary syndrome	0.000118	0.000229	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—INS—polycystic ovary syndrome	0.000118	0.000229	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—INS—polycystic ovary syndrome	0.000117	0.000228	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—IGF1—polycystic ovary syndrome	0.000114	0.000221	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—AKT2—polycystic ovary syndrome	0.000114	0.000221	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—IGF1—polycystic ovary syndrome	0.000113	0.00022	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—AKT2—polycystic ovary syndrome	0.000113	0.00022	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	0.000108	0.00021	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	0.000108	0.000209	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—IL6—polycystic ovary syndrome	8.7e-05	0.000169	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—IL6—polycystic ovary syndrome	8.68e-05	0.000169	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—VEGFA—polycystic ovary syndrome	7.43e-05	0.000144	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—VEGFA—polycystic ovary syndrome	7.41e-05	0.000144	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—IL6—polycystic ovary syndrome	5.14e-05	9.99e-05	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—IL6—polycystic ovary syndrome	5.13e-05	9.95e-05	CbGpPWpGaD
